Spring 2018 Volume 18 Number 2

Dear Reader

  • A message from IMF President Susie Novis

Scientific & Clinical

  • Immunotherapy in Myeloma: Monoclonal Antibodies
  • FDA Expands Approval of Xgeva in Patients with Myeloma
  • Updates on Drug Therapies for Multiple Myeloma

Education & Awareness

  • IMF Reaches Out to Community Healthcare Providers

Special Event

  • 2018 Myeloma Action Month!

Member Events

  • A 5K Walk to Support the Work That Wins the Battle
  • There Is No Such Thing As a Drop in the Bucket

Advocacy

  • Advocacy Team Gives Greater Voice to Myeloma Patients’ Needs

International Partners

  • IMF Holds Another Successful Patient & Family Seminar in Italy

 

Click here to download Myeloma Today
 


with support from:
Amgen, Celgene, Genentech, Janssen, and Takeda Oncology